| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 67011-43-2 | 3-(Acetylamino)-5-(Octanoylamino)-2,4,6-Triiodobenzoic Acid | C17H21I3N2O4 |
| 67011-44-3 | 3-Acetylamino-2,4,6-Triiodo-5-Valerylaminobenzoic Acid | C14H15I3N2O4 |
| 67012-81-1 | 21-O-Acetyl 6alpha-Hydroxy Cortisol | C23H32O7 |
| 67013-48-3 | 2-Iodo-Acetic Acid 2-[Methyl(7-Nitro-2,1,3-Benzoxadiazol-4-Yl)Amino]Ethyl Ester | C11H11IN4O5 |
| 67013-54-1 | 1-Chloro-2-(Dibromomethyl)Benzene | C7H5Br2Cl |
| 67013-94-9 | N,N-Dipropylcyclohexanecarboxamide | C13H25NO |
| 67013-95-0 | 1-[(6-Methyl-3-Cyclohexenyl)Carbonyl]Pyrrolidine | C12H19NO |
| 67013-98-3 | 1,4-Dioxaspiro(4.11)hexadecane | C9H12N6O4 |
| 67013-99-4 | 1,1'-(p-Phenylenebis(ureylene-p-phenylene))bis(3-methyl-1H-1,2,3-Triazolium bis(methyl sulfate) | C9H14N4O4 |
| 67014-02-2 | 4-acetylbenzamide | C9H9NO2 |
| 67014-03-3 | 4-Sulfonylphenylglyoxal | C8H6O5S |
| 67014-06-6 | N-[4-(2-Oxoacetyl)Phenyl]-Acetamide | C10H9NO3 |
| 67014-20-4 | 3-Iodobenzoylacebutolol | C21H25IN2O4 |
| 67014-36-2 | 5-Amino-6-methylbenzimidazolone | C8H9N3O |
| 67014-91-9 | 2-[2-[[5,6-Dimethoxy-3-(3-Sulphonatopropyl)-3H-Benzoselenazol-2-Ylidene]Methyl]But-1-Enyl]-3-Ethyl-5-Methoxybenzoxazolium | C27H32N2O7SSe |
| 67015-06-9 | N'-Hydroxypentanimidamide | C5H12N2O |
| 67015-08-1 | 2-(Dimethylamino)-N-Hydroxy-Ethanimidamide | C4H11N3O |
| 67015-63-8 | Sulfon | |
| 67015-85-4 | Solvent Red 176 | |
| 67016-65-3 | Pumiliotoxin B | C19H33NO3 |
| 67018-59-1 | N-Desethyl-Pirimiphos-Methyl | C9H16N3O3PS |
| 67018-85-3 | Norverapamil | C26H37ClN2O4 |
| 67019-13-0 | 9-[(4R)-4-Hydroxy-L-Proline]-Luteinizinghormone-Releasing Factor (Swine) | C55H75N17O14 |
| 67019-15-2 | 2-D-Phenylalanine-3-D-proline-6-D-phenylalanine-luteinizing hormone-releasing factor (swine) | C59H80N14O13 |
| 67019-78-7 | N-(2-Oxazolin-2-Yl)-1-(1-Phenylethyl)-1H-Imidazol-5-Amine | C8H12N4O4 |
| 67019-89-0 | Nona-2-6-Dienenitrile | C9H13N |
| 67019-91-4 | 3,7-Dibromo-dibenzofuran | C12H6Br2O |
| 67021-56-1 | 1-Hexyl-3-methylpyridinium bromide | C12H20N.Br |
| 67021-83-4 | 1H-Benzimidazol-7-ol | C7H6N2O |
| 67022-39-3 | Methotrexate gamma-Methyl Ester | C21H24N8O5 |
| 67022-41-7 | (2R,3R,4R)-2,3,4,8-Tetrahydroxy-6-methoxy-3-methyl-2,4-dihydro-1H-anthracene-9,10-dione | C16H16O7 |
| 67023-16-9 | N-(2-(Diethylamino)Ethyl)-2,6-Dimethyl-Acetanilide | C16H26N2O |
| 67023-43-2 | 1-[4-(Benzyloxy)-3-Methoxyphenyl]Methanamine | C15H18NO2 |
| 67023-80-7 | Ohchinin | C36H42O8 |
| 67023-81-8 | Ohchinin acetate | C38H44O9 |
| 67023-84-1 | (2E,6E)-1-Chloro-3,7,11-trimethyl-2,6,10-dodecatriene | C15H25Cl |
| 67024-46-8 | Isopropyl 2-Ethylhexanoate | C11H22O2 |
| 67024-75-3 | 7-Undecylquinolin-8-Ol | C20H29NO |
| 67025-22-3 | 1-Chloro-8-[4-(1,1,3,3-Tetramethylbutyl)Phenoxy]-3,6-Dioxaoctane | C20H33ClO3 |
| 67025-31-4 | 5-(3-Hydroxyphenyl)-2-Methyl-2-Azabicyclo(3.2.1)Octane | C14H20BrNO |
| 67025-94-9 | 6beta-(Bis(2-chloroethyl)amino)-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-3,14-diol | C24H34Cl4N2O3 |
| 67025-97-2 | (5alpha,6beta)-6-Amino-17-(cyclopropylmethyl)-4,5-epoxy-Morphinan-3,14-diol | C20H26N2O3 |
| 67026-10-2 | 1-Naphthaleneacetic acid, salt with 2,2',2''-nitrilotriethanol | C12H10O2.C6H15NO3 |
| 67026-12-4 | 5-{[4,6-Bis(1-Aziridinyl)-1,3,5-Triazine-2-Yl]Amino]-2-2-Dimethyl-1,3-Dioxane-5-Methanol | C14H22N6O3 |
| 67026-13-5 | 4,6-Di(Aziridin-1-Yl)-N-(2,2-Dimethyl-1,3-Dioxan-5-Yl)-1,3,5-Triazin-2-Amine | C13H20N6O2 |
| 67026-14-6 | 4,6-Di(Aziridin-1-Yl)-N-(2,2,5-Trimethyl-1,3-Dioxan-5-Yl)-1,3,5-Triazin-2-Amine | C14H22N6O2 |
| 67026-15-7 | 4,6-Di(Aziridin-1-Yl)-N-(5-Ethyl-2,2-Dimethyl-1,3-Dioxan-5-Yl)-1,3,5-Triazin-2-Amine | C15H24N6O2 |
| 67026-38-4 | 2-Cyano-1-(2-Ethoxyethyl)-3-(3-Pyridyl)Guanidine | C11H15N5O |
| 67026-39-5 | 2-Cyano-1-(2-Diethylaminoethyl)-3-(3-Pyridyl)Guanidine | C13H20N6 |
| 67026-46-4 | 2-Cyano-1-(1,3-Dimethylbutyl)-3-(4-Pyridyl)Guanidine | C13H19N5 |